ABSTRACT
Background Antimicrobial resistance (AMS) is recognized as one of the major threats of human health all around the world especially in low-and-middle income countries. Misuse or overuse of antimicrobials are considered as the major cause for developing AMS.
Methods This prospective observational study was conducted in outpatient’s department in a tertiary care hospital after obtaining prior ethics committee approval. The study was conducted during the month of April 2023.
RESULTS The study analysed 301 outpatient prescriptions over a period of 1 month. Of these prescriptions, Gender distribution was balanced, with 153 males (50.8%) and 148 females (49.2%). On average, the prescribed duration of antimicrobial therapy for all patients was found to be 6 days.
CONCLUSION This study underscores the urgency of addressing the issue of antibiotic overuse and misuse in outpatient care. By implementing evidence-based strategies and targeted educational initiatives, we can take significant strides towards preserving the effectiveness of antibiotics for future generations and ultimately improving patient outcomes. It is imperative that healthcare providers, administrators, and policymakers collaborate in promoting responsible antimicrobial prescribing practices to safeguard public health and combat the global threat of antibiotic resistance.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
no funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics approval was obtained from institutional ethics committee of Apollo hospitals, Chennai, Tamil Nadu, India (IEC Number: AVH-C-S-011/07-23).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
